​
​

Becton, Dickinson and Company (BDX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Becton, Dickinson and Company Revenue Highlights

Latest Revenue (Y)

$19.37B

Latest Revenue (Q)

$4.99B

Main Segment (Y)

Life Sciences

Main Geography (Y)

UNITED STATES

Becton, Dickinson and Company Revenue by Period

Becton, Dickinson and Company Revenue by Year

DateRevenueChange
2023-09-30$19.37B2.66%
2022-09-30$18.87B-6.81%
2021-09-30$20.25B18.29%
2020-09-30$17.12B-1.00%
2019-09-30$17.29B8.18%
2018-09-30$15.98B32.17%
2017-09-30$12.09B-3.12%
2016-09-30$12.48B21.41%
2015-09-30$10.28B21.74%
2014-09-30$8.45B4.87%
2013-09-30$8.05B4.48%
2012-09-30$7.71B-1.54%
2011-09-30$7.83B6.19%
2010-09-30$7.37B2.95%
2009-09-30$7.16B0.07%
2008-09-30$7.16B12.52%
2007-09-30$6.36B9.00%
2006-09-30$5.83B7.76%
2005-09-30$5.41B9.73%
2004-09-30$4.93B8.98%
2003-09-30$4.53B12.27%
2002-09-30$4.03B7.43%
2001-09-30$3.75B3.76%
2000-09-30$3.62B5.85%
1999-09-30$3.42B9.67%
1998-09-30$3.12B10.90%
1997-09-30$2.81B1.47%
1996-09-30$2.77B2.11%
1995-09-30$2.71B5.98%
1994-09-30$2.56B3.82%
1993-09-30$2.47B-

Becton, Dickinson and Company generated $19.37B in revenue during NA 2023, up 2.66% compared to the previous quarter, and up 121.20% compared to the same period a year ago.

Becton, Dickinson and Company Revenue by Quarter

DateRevenueChange
2024-06-30$4.99B-1.09%
2024-03-31$5.04B7.20%
2023-12-31$4.71B-7.49%
2023-09-30$5.09B4.28%
2023-06-30$4.88B1.18%
2023-03-31$4.82B5.12%
2022-12-31$4.59B-3.68%
2022-09-30$4.76B2.59%
2022-06-30$4.64B-7.38%
2022-03-31$5.01B6.21%
2021-12-31$4.72B-8.12%
2021-09-30$5.13B5.01%
2021-06-30$4.89B-0.35%
2021-03-31$4.91B-7.68%
2020-12-31$5.32B11.10%
2020-09-30$4.78B24.10%
2020-06-30$3.85B-9.36%
2020-03-31$4.25B0.66%
2019-12-31$4.22B-7.83%
2019-09-30$4.58B5.38%
2019-06-30$4.35B3.69%
2019-03-31$4.20B0.84%
2018-12-31$4.16B-5.50%
2018-09-30$4.40B2.90%
2018-06-30$4.28B1.33%
2018-03-31$4.22B37.08%
2017-12-31$3.08B-2.72%
2017-09-30$3.17B4.32%
2017-06-30$3.04B2.22%
2017-03-31$2.97B1.61%
2016-12-31$2.92B-9.56%
2016-09-30$3.23B1.03%
2016-06-30$3.20B4.27%
2016-03-31$3.07B2.71%
2015-12-31$2.99B-2.42%
2015-09-30$3.06B-1.92%
2015-06-30$3.12B52.12%
2015-03-31$2.05B-
2014-12-31$2.05B-6.86%
2014-09-30$2.20B2.09%
2014-06-30$2.16B4.10%
2014-03-31$2.07B2.83%
2013-12-31$2.02B-4.08%
2013-09-30$2.10B2.34%
2013-06-30$2.05B2.61%
2013-03-31$2.00B5.27%
2012-12-31$1.90B-3.40%
2012-09-30$1.97B-0.67%
2012-06-30$1.98B-0.52%
2012-03-31$1.99B5.47%
2011-12-31$1.89B-7.96%
2011-09-30$2.05B1.82%
2011-06-30$2.01B4.79%
2011-03-31$1.92B4.34%
2010-12-31$1.84B6.32%
2010-09-30$1.73B-7.76%
2010-06-30$1.88B1.81%
2010-03-31$1.84B-3.75%
2009-12-31$1.92B1.00%
2009-09-30$1.90B4.26%
2009-06-30$1.82B4.56%
2009-03-31$1.74B0.42%
2008-12-31$1.73B-5.56%
2008-09-30$1.84B-1.71%
2008-06-30$1.87B6.91%
2008-03-31$1.75B-

Becton, Dickinson and Company generated $4.99B in revenue during Q3 2024, up -1.09% compared to the previous quarter, and up 103.51% compared to the same period a year ago.

Becton, Dickinson and Company Revenue Breakdown

Becton, Dickinson and Company Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceSep 23Sep 22Sep 21Sep 20Sep 19
Medical$2.00B----
Life Sciences$2.30B----
Consumables$2.00B$1.90B$2.50B$2.60B$2.80B
Products and/or Services$2.30B$2.50B$2.10B$1.90B$1.80B

Becton, Dickinson and Company's latest annual revenue breakdown by segment (product or service), as of Sep 23: Life Sciences (26.74%), Products and/or Services (26.74%), Medical (23.26%), and Consumables (23.26%).

Quarterly Revenue by Product

Product/ServiceJun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Medical$2.10B$1.11B$1.05B$581.00M$552.00M$486.00M$425.00M-------------
Life Sciences$2.30B$1.30B$1.29B$930.00M$1.18B$377.00M$393.00M-------------
Interventional-$489.00M$454.00M$318.00M$306.00M$293.00M$297.00M-------------
Consumables--$2.20B-$2.10B$2.20B$1.90B$2.10B$2.40B$2.40B$2.80B$2.70B$2.60B$2.60B$2.70B$2.70B----
Products and/or Services--$2.20B-$2.50B$2.50B$2.50B$2.20B$2.20B$2.10B$1.90B$1.90B$1.90B$1.60B$1.70B$1.80B----

Becton, Dickinson and Company's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Life Sciences (52.27%), and Medical (47.73%).

Becton, Dickinson and Company Revenue Breakdown by Country

Annual Revenue by Country

CountrySep 23Sep 22Sep 21Sep 20Sep 19
Europe$4.24B$3.48B$3.36B--
UNITED STATES$11.11B$10.72B$10.97B$9.72B$9.73B
Others Country$1.10B$1.06B$1.25B$1.35B$1.48B
EMEA$4.24B$4.04B$4.75B--
Asia$2.91B$3.05B$3.27B$2.57B$2.73B

Becton, Dickinson and Company's latest annual revenue breakdown by geography, as of Sep 23: UNITED STATES (47.06%), Europe (17.97%), EMEA (17.97%), Asia (12.33%), and Others Country (4.67%).

Quarterly Revenue by Country

CountryJun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Non-US$2.10B$2.14B$1.96B$2.21B$2.11B$2.09B$1.86B$2.05B$2.00B$2.20B$2.14B$2.33B$2.32B$2.45B$2.19B$2.03B$1.74B$1.84B$1.79B$2.02B
UNITED STATES$2.89B$2.91B$2.75B$2.88B$2.77B$2.73B$2.73B$2.71B$2.64B$2.81B$2.85B$2.80B$2.57B$2.46B$3.13B$2.75B$2.12B$2.42B$2.43B$2.56B

Becton, Dickinson and Company's latest quarterly revenue breakdown by geography, as of Jun 24: UNITED STATES (57.95%), and Non-US (42.05%).

Becton, Dickinson and Company Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
BDXBecton, Dickinson and Company$19.37B$4.99B
ALCAlcon$10.09B$2.46B
RMDResMed$4.69B$1.22B
HOLXHologic$4.03B$1.01B
XRAYDENTSPLY SIRONA$3.96B$951.00M
COOCooper Companies$3.59B$1.00B
TFXTeleflex$2.97B$764.38M
WSTWest Pharmaceutical Services$2.95B$746.90M
ICUIICU Medical$2.26B$589.13M
HAEHaemonetics$1.31B$336.17M
RGENRepligen$638.76M$154.07M
ANGOAngioDynamics$303.91M$67.49M

BDX Revenue FAQ

What is Becton, Dickinson and Company’s yearly revenue?

Becton, Dickinson and Company's yearly revenue for 2023 was $19.37B, representing an increase of 2.66% compared to 2022. The company's yearly revenue for 2022 was $18.87B, representing a decrease of -6.81% compared to 2021. BDX's yearly revenue for 2021 was $20.25B, representing an increase of 18.29% compared to 2020.

What is Becton, Dickinson and Company’s quarterly revenue?

Becton, Dickinson and Company's quarterly revenue for Q3 2024 was $4.99B, a -1.09% decrease from the previous quarter (Q2 2024), and a 2.30% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $5.04B, a 7.20% increase from the previous quarter (Q1 2024), and a 4.65% increase year-over-year (Q2 2023). BDX's quarterly revenue for Q1 2024 was $4.71B, a -7.49% decrease from the previous quarter (Q4 2023), and a 2.62% increase year-over-year (Q1 2023).

What is Becton, Dickinson and Company’s revenue growth rate?

Becton, Dickinson and Company's revenue growth rate for the last 3 years (2021-2023) was -4.33%, and for the last 5 years (2019-2023) was 12.04%.

What are Becton, Dickinson and Company’s revenue streams?

Becton, Dickinson and Company's revenue streams in p 23 are Medical, Life Sciences, Consumables, and Products and/or Services. Medical generated $2B in revenue, accounting 23.26% of the company's total revenue Life Sciences generated $2.3B in revenue, accounting 26.74% of the company's total revenue Consumables generated $2B in revenue, accounting 23.26% of the company's total revenue, up 5.26% year-over-year. Products and/or Services generated $2.3B in revenue, accounting 26.74% of the company's total revenue, down -8.00% year-over-year.

What is Becton, Dickinson and Company’s main source of revenue?

For the fiscal year ending Sep 23, the largest source of revenue of Becton, Dickinson and Company was Life Sciences. This segment made a revenue of $2.3B, representing 26.74% of the company's total revenue.